Alnylam Pharmaceuticals Inc (ALNY)
246.88
-1.91
(-0.77%)
USD |
NASDAQ |
Nov 21, 16:00
249.68
+2.80
(+1.13%)
After-Hours: 20:00
Alnylam Pharmaceuticals Price to Book Value: 984.20 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 991.81 |
| November 19, 2024 | 933.93 |
| November 18, 2024 | 925.96 |
| November 15, 2024 | 939.07 |
| November 14, 2024 | 1028.17 |
| November 13, 2024 | 1054.84 |
| November 12, 2024 | 1072.18 |
| November 11, 2024 | 1115.52 |
| November 08, 2024 | 1105.99 |
| November 07, 2024 | 1085.22 |
| November 06, 2024 | 1088.37 |
| November 05, 2024 | 1057.59 |
| November 04, 2024 | 1076.17 |
| November 01, 2024 | 1091.96 |
| October 31, 2024 | 1062.77 |
| October 30, 2024 | 1122.17 |
| October 29, 2024 | 1134.93 |
| October 28, 2024 | 1143.78 |
| October 25, 2024 | 1135.61 |
| October 24, 2024 | 1169.54 |
| October 23, 2024 | 1174.24 |
| October 22, 2024 | 1180.65 |
| October 21, 2024 | 1162.85 |
| October 18, 2024 | 1178.46 |
| October 17, 2024 | 1181.73 |
| Date | Value |
|---|---|
| October 16, 2024 | 1196.86 |
| October 15, 2024 | 1144.33 |
| October 14, 2024 | 1128.24 |
| October 11, 2024 | 1132.23 |
| October 10, 2024 | 1109.53 |
| October 09, 2024 | 1078.79 |
| October 08, 2024 | 1079.94 |
| October 07, 2024 | 1062.34 |
| October 04, 2024 | 1067.20 |
| October 03, 2024 | 1073.33 |
| October 02, 2024 | 1081.37 |
| October 01, 2024 | 1099.33 |
| September 30, 2024 | 1095.23 |
| September 27, 2024 | |
| September 26, 2024 | |
| September 25, 2024 | |
| September 24, 2024 | |
| September 23, 2024 | |
| September 20, 2024 | |
| September 19, 2024 | |
| September 18, 2024 | |
| September 17, 2024 | |
| September 16, 2024 | |
| September 13, 2024 | |
| September 12, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
7.319
Minimum
Mar 12 2020
1196.86
Maximum
Oct 16 2024
84.88
Average
19.10
Median
Jan 21 2021
Price to Book Value Benchmarks
| Pfizer Inc | 1.543 |
| BridgeBio Pharma Inc | -- |
| Gilead Sciences Inc | 6.058 |
| Johnson & Johnson | 5.336 |
| Regeneron Pharmaceuticals Inc | 2.790 |
Price to Book Value Related Metrics
| PS Ratio | 14.94 |
| Price to Free Cash Flow | 1948.40 |
| Price | 246.88 |
| Earnings Yield | -1.06% |
| Market Cap | 31.84B |